Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Phase 2 Terminated
19 enrolled 4 charts
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
Phase 2 Completed
70 enrolled
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
Phase 2 Completed
58 enrolled 6 charts
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Phase 1/2 Terminated
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
Phase 2 Completed
80 enrolled
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
Phase 2 Terminated
30 enrolled
Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
Phase 2 Completed
21 enrolled
Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer
Phase 2 Unknown
70 enrolled